Losing weight through Semaglutide treatment can significantly reduce the risk of developing weight-related conditions such as type 2 diabetes, high blood pressure, and heart disease
The body has adapted, and side effects typically diminish significantly
Case reports with a small number of patients are not generalizable, though they do suggest that some women may experience a normal pregnancy if they transition off a GLP-1 medication during the first trimester
Cytoprotection Research has also examined protective effects in gastrointestinal tissues together with broader cellular stress responses
In addition, some interventions, such as prebiotics, probiotics, antidiabetic drugs, and bariatric surgery, changed the composition and function of the gut microbiota and then exerted benefits on the body, suggesting that gut microbiota is a target for diseases, such as obesity and T2D